374 related articles for article (PubMed ID: 18848812)
1. In utero onset of long QT syndrome with atrioventricular block and spontaneous or lidocaine-induced ventricular tachycardia: compound effects of hERG pore region mutation and SCN5A N-terminus variant.
Lin MT; Wu MH; Chang CC; Chiu SN; Thériault O; Huang H; Christé G; Ficker E; Chahine M
Heart Rhythm; 2008 Nov; 5(11):1567-74. PubMed ID: 18848812
[TBL] [Abstract][Full Text] [Related]
2. Look beyond the hERG mutation: a neutral SCN5A variant may turn lidocaine into a threat.
Lindegger N; Mongillo M
Heart Rhythm; 2008 Nov; 5(11):1575-6. PubMed ID: 18984535
[No Abstract] [Full Text] [Related]
3. Long QT and Brugada syndrome gene mutations in New Zealand.
Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
[TBL] [Abstract][Full Text] [Related]
4. Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family.
Koo SH; Teo WS; Ching CK; Chan SH; Lee EJ
Ann Acad Med Singap; 2007 Jun; 36(6):394-8. PubMed ID: 17597962
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome.
Cuneo BF; Etheridge SP; Horigome H; Sallee D; Moon-Grady A; Weng HY; Ackerman MJ; Benson DW
Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):946-51. PubMed ID: 23995044
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients.
Fodstad H; Bendahhou S; Rougier JS; Laitinen-Forsblom PJ; Barhanin J; Abriel H; Schild L; Kontula K; Swan H
Ann Med; 2006; 38(4):294-304. PubMed ID: 16754261
[TBL] [Abstract][Full Text] [Related]
7. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
Antzelevitch C
J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism for LQT3 with 2:1 block: a pore-lining mutation in Nav1.5 significantly affects voltage-dependence of activation.
Horne AJ; Eldstrom J; Sanatani S; Fedida D
Heart Rhythm; 2011 May; 8(5):770-7. PubMed ID: 21193062
[TBL] [Abstract][Full Text] [Related]
9. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block.
Lupoglazoff JM; Cheav T; Baroudi G; Berthet M; Denjoy I; Cauchemez B; Extramiana F; Chahine M; Guicheney P
Circ Res; 2001 Jul; 89(2):E16-21. PubMed ID: 11463728
[TBL] [Abstract][Full Text] [Related]
10. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.
Barc J; Briec F; Schmitt S; Kyndt F; Le Cunff M; Baron E; Vieyres C; Sacher F; Redon R; Le Caignec C; Le Marec H; Probst V; Schott JJ
J Am Coll Cardiol; 2011 Jan; 57(1):40-7. PubMed ID: 21185499
[TBL] [Abstract][Full Text] [Related]
11. The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology.
Priori SG; Cantù F; Schwartz PJ
Schweiz Med Wochenschr; 1996 Oct; 126(41):1727-31. PubMed ID: 8893413
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.
Rajamani S; Eckhardt LL; Valdivia CR; Klemens CA; Gillman BM; Anderson CL; Holzem KM; Delisle BP; Anson BD; Makielski JC; January CT
Br J Pharmacol; 2006 Nov; 149(5):481-9. PubMed ID: 16967046
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation in SCN5A, delQKP 1507-1509, causing long QT syndrome: role of Q1507 residue in sodium channel inactivation.
Keller DI; Acharfi S; Delacrétaz E; Benammar N; Rotter M; Pfammatter JP; Fressart V; Guicheney P; Chahine M
J Mol Cell Cardiol; 2003 Dec; 35(12):1513-21. PubMed ID: 14654377
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome.
Liu L; Hayashi K; Kaneda T; Ino H; Fujino N; Uchiyama K; Konno T; Tsuda T; Kawashiri MA; Ueda K; Higashikata T; Shuai W; Kupershmidt S; Higashida H; Yamagishi M
Heart Rhythm; 2013 Jan; 10(1):61-7. PubMed ID: 23010577
[TBL] [Abstract][Full Text] [Related]
15. A revised view of cardiac sodium channel "blockade" in the long-QT syndrome.
Kambouris NG; Nuss HB; Johns DC; Marbán E; Tomaselli GF; Balser JR
J Clin Invest; 2000 Apr; 105(8):1133-40. PubMed ID: 10772658
[TBL] [Abstract][Full Text] [Related]
16. A hERG mutation E1039X produced a synergistic lesion on I
Wu J; Mizusawa Y; Ohno S; Ding WG; Higaki T; Wang Q; Kohjitani H; Makiyama T; Itoh H; Toyoda F; James AF; Hancox JC; Matsuura H; Horie M
Sci Rep; 2018 Feb; 8(1):3129. PubMed ID: 29449639
[TBL] [Abstract][Full Text] [Related]
17. Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative results.
Tester DJ; Cronk LB; Carr JL; Schulz V; Salisbury BA; Judson RS; Ackerman MJ
Heart Rhythm; 2006 Jul; 3(7):815-21. PubMed ID: 16818214
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
[TBL] [Abstract][Full Text] [Related]
19. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.
Kapplinger JD; Tester DJ; Salisbury BA; Carr JL; Harris-Kerr C; Pollevick GD; Wilde AA; Ackerman MJ
Heart Rhythm; 2009 Sep; 6(9):1297-303. PubMed ID: 19716085
[TBL] [Abstract][Full Text] [Related]
20. A novel SCN5A mutation manifests as a malignant form of long QT syndrome with perinatal onset of tachycardia/bradycardia.
Chang CC; Acharfi S; Wu MH; Chiang FT; Wang JK; Sung TC; Chahine M
Cardiovasc Res; 2004 Nov; 64(2):268-78. PubMed ID: 15485686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
